iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
139.96
+0.18 (0.13%)
May 14, 2025, 10:00 AM - Market open
iRhythm Technologies Employees
iRhythm Technologies had 2,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$309,294
Profits / Employee
-$49,161
Market Cap
4.47B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IRTC News
- 11 days ago - Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts - Benzinga
- 12 days ago - iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection - GlobeNewsWire
- 14 days ago - iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference - GlobeNewsWire
- 16 days ago - iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring - GlobeNewsWire
- 26 days ago - iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewsWire
- 4 weeks ago - iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability - GlobeNewsWire
- 6 weeks ago - iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection - GlobeNewsWire